Related references
Note: Only part of the references are listed.Myeloma today: Disease definitions and treatment advances
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma
Ravi Vij et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation
Nina Shah et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Treatment options for relapsed and refractory multiple myeloma
Ajay K. Nooka et al.
BLOOD (2015)
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality
Joaquin Martinez-Lopez et al.
BLOOD (2015)
Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era
Hiroyuki Takamatsu et al.
CANCER SCIENCE (2015)
How we manage autologous stem cell transplantation for patients with multiple myeloma
Morie A. Gertz et al.
BLOOD (2014)
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
S. K. Kumar et al.
LEUKEMIA (2014)
Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis
J. Lu et al.
BLOOD CANCER JOURNAL (2014)
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. Moreau et al.
ANNALS OF ONCOLOGY (2013)
Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma
Prashant Kapoor et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
Joseph R. Mikhael et al.
MAYO CLINIC PROCEEDINGS (2013)
Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial
Philippe Moreau et al.
BLOOD (2011)
Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction
Morie A. Gertz et al.
BLOOD (2010)
Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation
Jin Seok Kim et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
Juan Jose Lahuerta et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Patterns of survival in multiple myeloma:: A population-based study of patients diagnosed in Sweden from 1973 to 2003
Sigurdur Yngvi Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Risk of multiple myeloma following medication use and medical conditions: A case-control study in Connecticut women
Ola Landgren et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy
S Kumar et al.
BONE MARROW TRANSPLANTATION (2004)
Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma
S Singhal et al.
BONE MARROW TRANSPLANTATION (2002)
Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation
SV Rajkumar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PLAS3
LH Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
